Yale Cancer Center Advanced Training Program for Physician-Scientists (YCC-ATPP)

耶鲁大学癌症中心医师科学家高级培训计划 (YCC-ATPP)

• 批准号: 9789506
• 负责人: Lieping Chen
• 金额: $ 32.93万
• 依托单位: YALE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-08-01 至 2024-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9789506
• 关键词: Physicians; Scientist; Training Programs; Yale Cancer Center

PROJECT SUMMARY/ABSTRACT This resubmission titled “Yale Cancer Center Advanced Training Program for Physician-scientists (YCC-ATPP)” requests five years of support for an intensive hematology and medical oncology (Heme/MedOnc) fellowship research training program at the Yale School of Medicine (YSM)/Yale Cancer Center (YCC). Our record of training Heme/MedOnc fellows is strong. Our trainees have gone on to major positions of leadership and success in academic and clinical hematology and oncology settings. Since 1987, 151 fellows have completed the Heme/MedOnc Fellowship Program (originally as separate disciplines; now as a joint program since 2012), and 46 of the 72 graduates who completed the program within the last 10 years work in academic positions, many with independent funding. Bolstered by the recent investment in our cancer center by Yale University and Yale-New Haven Hospital, including increased institutional commitment and faculty recruitment in recent years (many with peer-reviewed funding), we believe the structure and support provided by this T32 will allow trainees to achieve even greater success and will further increase the numbers of accomplished independent physician-scientist leaders completing our program. This T32 will build on a foundation of excellence established during clinical training in our Heme/MedOnc Fellowship Program, from which fellows will be able to apply to this program. As such, the prospective trainees will have already received an MD or MD/PhD degree, completed internal medicine residency, and 2 years of clinical fellowship training in Heme/MedOnc. This T32 program will select the most highly qualified and diverse candidates from this group who wish to pursue a career in cancer research and numerous procedures have been put in place to ensure the recruitment, quality mentorship, and retention of under-represented minority fellows. This advanced training program will provide outstanding mentored basic, translational, clinical, and outcome-based cancer research experiences from senior and expert junior faculty in a highly collegial, collaborative, and integrative institutional environment. This program is designed to provide essential financial support and ensure precious protected time is given to our fellows for research, allowing them to establish themselves early on as physician-scientists, and paving the way towards a successful academic career. Along these lines, the program includes career development planning and mentorship committees including scientists and physicians with knowledge and experience in the trainee’s research field to provide guidance throughout the length of the program. At the conclusion of their training, it is our goal that individuals supported by this T32 will have developed the skills necessary to function independently, including the ability to design, initiate, and complete research projects, and to effectively write grants and manuscripts. The T32 will firmly position Heme/MedOnc fellows as independent clinical, translational, or basic cancer researcher leaders of tomorrow.

项目概要/摘要 这次重新提交的标题为“耶鲁癌症中心医师科学家高级培训计划” (YCC-ATPP)”请求为强化血液学和肿瘤内科提供五年支持 耶鲁大学医学院 (YSM)/耶鲁大学癌症中心 (Heme/MedOnc) 奖学金研究培训计划 中心（YCC）。我们对 Heme/MedOnc 研究员的培训记录非常出色。我们的学员已经升入专业 在学术和临床血液学和肿瘤学领域的领导地位和成功。自1987年以来， 151 名研究员完成了 Heme/MedOnc 奖学金计划（最初作为单独的学科；现在作为 自 2012 年以来的联合项目），以及过去 10 年内完成该项目的 72 名毕业生中的 46 名 从事学术职务，其中许多有独立资助。得益于最近对癌症的投资 耶鲁大学和耶鲁纽黑文医院的中心，包括增加机构承诺和 近年来的教师招聘（许多都有同行评审的资金），我们相信结构和支持 这台T32提供的服务将使学员取得更大的成功，并进一步增加人数 完成我们项目的杰出独立医师科学家领导者。 该 T32 将建立在我们的临床培训期间建立的卓越基础之上。 Heme/MedOnc 奖学金计划，研究员可以通过该计划申请该计划。因此， 未来的学员将已经获得医学博士或医学博士/博士学位，完成内科医学课程 住院医师实习期，以及 2 年 Heme/MedOnc 临床研究员培训。这个T32程序将选择最多的 来自该群体的高素质且多样化的候选人，他们希望从事癌症研究和职业生涯 已经制定了许多程序来确保招聘、优质指导和留住人才 少数族裔研究员的代表性不足。该高级培训计划将提供出色的指导基础、 来自资深和初级专家教师的转化、临床和基于结果的癌症研究经验 高度合议、协作和一体化的制度环境。该计划旨在提供 必要的财政支持，并确保为我们的研究员提供宝贵的受保护时间进行研究，从而使 他们很早就确立了自己作为医学科学家的地位，并为成功的道路铺平了道路 学术生涯。沿着这些思路，该计划包括职业发展规划和指导 由在受训者研究领域拥有知识和经验的科学家和医生组成的委员会 在整个计划期间提供指导。在他们的培训结束时，我们的目标是 受此 T32 支持的个人将发展出独立运作所需的技能，包括 设计、启动和完成研究项目以及有效撰写资助和手稿的能力。 T32 将坚定地将 Heme/MedOnc 研究员定位为独立的临床、转化或基础癌症 明天的研究领袖。